☆ 4.5 Review

European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate

JOURNAL OF HEADACHE AND PAIN (2023)

Related references

Note: Only part of the references are listed.

Review Clinical Neurology

The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis

Christian Lampl et al.

Summary: This article conducted a systematic review and network meta-analysis to compare the safety and efficacy of different drugs for migraine prophylaxis. The study found that CGRP receptor monoclonal antibodies, gepants, and topiramate have the best efficacy in reducing monthly migraine days. Additionally, there is evidence supporting the efficacy of beta-blockers, valproate, and amitriptyline.

JOURNAL OF HEADACHE AND PAIN (2023)

Add to Collection

Article Clinical Neurology

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline

Christian Lampl et al.

Summary: The objective of this paper is to critically re-evaluate the published trials on amitriptyline for migraine prophylaxis. Through a systematic review methodology, the authors searched various databases for randomized trials comparing amitriptyline with placebo for migraine prophylaxis. They assessed the outcomes of interest using established criteria and evaluated the risk of bias and certainty of evidence. The results indicated that amitriptyline may have a prophylactic role in reducing migraine days, but further research is needed.

JOURNAL OF HEADACHE AND PAIN (2023)

Add to Collection

Review Clinical Neurology

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizine

Christina I. Deligianni et al.

Summary: This study aimed to evaluate the efficacy of flunarizine as a prophylactic treatment for migraines. Through a systematic search and analysis of relevant literature, it was found that flunarizine may have the potential to reduce the frequency of monthly migraine attacks, but with some risk of adverse events.

JOURNAL OF HEADACHE AND PAIN (2023)

Add to Collection

Article Clinical Neurology

TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine

Debashish Chowdhury et al.

Summary: The TOP-PRO study aimed to assess the efficacy and tolerability of propranolol compared to topiramate for the prevention of chronic migraine, and found that propranolol was non-inferior and not superior to topiramate with comparable tolerability.

CEPHALALGIA (2022)

Add to Collection

Article Clinical Neurology

Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial

Uwe Reuter et al.

Summary: In this study comparing erenumab to topiramate for migraine prophylaxis, erenumab demonstrated a more favorable tolerability and efficacy profile, with fewer patients discontinuing medication due to adverse events and significantly more patients achieving a >= 50% reduction in monthly migraine days.

CEPHALALGIA (2022)

Add to Collection

Review Respiratory System

Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysis

Tyler Pitre et al.

Summary: Through the evaluation of 48 eligible studies, it was found that nintedanib, pirfenidone, and sildenafil may reduce the mortality of IPF patients; nintedanib, nintedanib+sildenafil, pirfenidone, pamrevlumab, and pentraxin may reduce the decline in lung capacity in IPF patients; sildenafil may reduce the likelihood of acute exacerbation and hospitalizations; while corticosteroids+azathioprine+N-acetylcysteine increased the risk of serious adverse events compared to placebo.

THORAX (2022)

Add to Collection

Article Obstetrics & Gynecology

Effect of Topiramate on Serum Etonogestrel Concentrations Among Contraceptive Implant Users

Aaron Lazorwitz et al.

Summary: The pharmacokinetic interaction between topiramate and etonogestrel in contraceptive implant users resulted in decreased serum etonogestrel concentrations, potentially impacting contraceptive efficacy.

OBSTETRICS AND GYNECOLOGY (2022)

Add to Collection

Article Clinical Neurology

Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability

Marte-Helene Bjork et al.

Summary: This study found that prenatal exposure to antiseizure medication is associated with an increased risk of neurodevelopmental disorders in children, especially when exposed to topiramate, valproate, and certain duotherapies.

JAMA NEUROLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Core outcome set for preventive intervention trials in chronic and episodic migraine (COSMIG): an international, consensus-derived and multistakeholder initiative

Kirstie Haywood et al.

Summary: This study describes the development of a core outcome set for migraine (COSMIG) through international, multistakeholder consensus, resulting in the identification of two core domains: migraine-specific pain and migraine-specific quality of life. The study used a two-stage approach, including expert panel Delphi studies and a consensus meeting to determine core domains and assessment methods.

BMJ OPEN (2021)

Add to Collection

Article Clinical Neurology

Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020

Henrik W. Schytz et al.

Summary: The Danish Headache Society has launched a third version of the guidelines for the diagnosis, organization, and treatment of the most common types of headaches and facial pain, aiming to educate and advocate for the needs of patients. The guidelines provide information on examining and diagnosing headache patients, organizing headache treatment, as well as characteristics, diagnosis, and treatment for each common type of headache disorders.

JOURNAL OF HEADACHE AND PAIN (2021)

Add to Collection

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Review Pharmacology & Pharmacy

Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments

Farzin Zobdeh et al.

Summary: Migraine is a prevalent disease globally and limited therapy response requires individually adjusted treatment. The pharmaceutical development for acute and chronic migraine has significantly intensified in recent years, with an expansion of drug targets and increased number of clinical trials.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Add to Collection

Review Clinical Neurology

CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis

Florian Frank et al.

Summary: The approval of monoclonal antibodies for the prevention of migraine has revolutionized treatment for patients, although oral preventative medications are still considered first-line treatments. This study aimed to compare the efficacy of three commonly prescribed migraine preventative medication classes, finding that topiramate, botulinum toxin type A, and monoclonal antibodies had higher odds ratios in achieving a 50% response rate compared to placebo. Topiramate had the greatest effect size but also the highest drop-out rate among the three.

CEPHALALGIA (2021)

Add to Collection

Review Clinical Neurology

Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis

Lucas Hendrik Overeem et al.

Summary: This study indirectly compared the clinical efficacy and safety of CGRP antibodies and topiramate in episodic migraine prophylaxis through meta-analysis. The results showed no difference in reducing migraine days between the two, but the safety profile of CGRP antibodies was better.

CNS DRUGS (2021)

Add to Collection

Review Medicine, General & Internal

Drug treatments for covid-19: living systematic review and network meta-analysis

Reed A. C. Siemieniuk et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Article Clinical Neurology

Real world preventative drug management of migraine among Spanish neurologists

D. Garcia-Azorin et al.

JOURNAL OF HEADACHE AND PAIN (2019)

Add to Collection

Article Clinical Neurology

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine

John F. Rothrock et al.

HEADACHE (2019)

Add to Collection

Article Psychiatry

How to perform a meta-analysis with R: a practical tutorial

Sara Balduzzi et al.

EVIDENCE-BASED MENTAL HEALTH (2019)

Add to Collection

Article Clinical Neurology

Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults

Cristina Tassorelli et al.

CEPHALALGIA (2018)

Add to Collection

Article Clinical Neurology

Topiramate in Migraine Prevention: A 2016 Perspective

Stephen D. Silberstein

HEADACHE (2017)

Add to Collection

Article Mathematical & Computational Biology

Methods for including information from multi-arm trials in pairwise meta-analysis

Gerta Ruecker et al.

RESEARCH SYNTHESIS METHODS (2017)

Add to Collection

Review Medicine, General & Internal

Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes

Areti Angeliki Veroniki et al.

BMC MEDICINE (2017)

Add to Collection

Article Clinical Neurology

Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial

K.-L. Lai et al.

ACTA NEUROLOGICA SCANDINAVICA (2016)

Add to Collection

Review Clinical Neurology

Antiepileptics in migraine prophylaxis: An updated Cochrane review

Wim M. Mulleners et al.

CEPHALALGIA (2015)

Add to Collection

Review Pharmacology & Pharmacy

Efficacy and mechanism of anticonvulsant drugs in migraine

Jan Hoffmann et al.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)

Add to Collection

Review Medicine, General & Internal

Topiramate for the prophylaxis of episodic migraine in adults

Mattias Linde et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)

Add to Collection

Article Anesthesiology

A Randomized, One-Year Clinical Trial Comparing the Efficacy of Topiramate, Flunarizine, and a Combination of Flunarizine and Topiramate in Migraine Prophylaxis

Ning Luo et al.

PAIN MEDICINE (2012)

Add to Collection

Meeting Abstract Clinical Neurology

The safety and efficacy of occipital nerve stimulation for the management of chronic migraine

S. Silberstein et al.

CEPHALALGIA (2011)

Add to Collection

Review Clinical Neurology

Zonisamide Versus Topiramate in Migraine Prophylaxis: A Double-Blind Randomized Clinical Trial

Seyed Ehsan Mohammadianinejad et al.

CLINICAL NEUROPHARMACOLOGY (2011)

Add to Collection

Article Clinical Neurology

Topiramate intervention to prevent transformation of episodic migraine: The topiramate INTREPID study

Richard B. Lipton et al.

CEPHALALGIA (2011)

Add to Collection

Article Computer Science, Interdisciplinary Applications

Conducting Meta-Analyses in R with the metafor Package

Wolfgang Viechtbauer

JOURNAL OF STATISTICAL SOFTWARE (2010)

Add to Collection

Article Pharmacology & Pharmacy

Topiramate Versus Amitriptyline in Migraine Prevention: A 26-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Noninferiority Trial in Adult Migraineurs

David W. Dodick et al.

CLINICAL THERAPEUTICS (2009)

Add to Collection

Article Clinical Neurology

Topiramate Treatment of Chronic Migraine: A Randomized, Placebo-Controlled Trial of Quality of Life and Other Efficacy Measures

Stephen Silberstein et al.

HEADACHE (2009)

Add to Collection

Article Clinical Neurology

A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine

Kader Keskinbora et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2008)

Add to Collection

Editorial Material Medicine, General & Internal

GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations

Gordon H. Guyatt et al.

BRITISH MEDICAL JOURNAL (2008)

Add to Collection

Article Clinical Neurology

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study

H-C Diener et al.

CEPHALALGIA (2007)

Add to Collection

Article Clinical Neurology

Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial

Stephen D. Silberstein et al.

HEADACHE (2007)

Add to Collection

Review Pharmacology & Pharmacy

Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms

Paolo Calabresi et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2007)

Add to Collection

Article Pharmacology & Pharmacy

Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine With/Without aura in adults: A randomized, placebo-controlled, double-blind, 12-week pilot study

Stephen D. Silberstein et al.

CLINICAL THERAPEUTICS (2006)

Add to Collection

Article Clinical Neurology

Evidence-based guidelines for migraine headache in the primary care setting: Pharmacological management for prevention of migraine

Alan Rapoport et al.

HEADACHE (2006)

Add to Collection

Article Clinical Neurology

Suppression of cortical spreading depression in migraine prophylaxis

C Ayata et al.

ANNALS OF NEUROLOGY (2006)

Add to Collection

Article Clinical Neurology

Migraine: New molecular mechanisms

D Pietrobon

NEUROSCIENTIST (2005)

Add to Collection

Article Clinical Neurology

Topiramate in migraine prevention - Results of a large controlled trial

SD Silberstein et al.

ARCHIVES OF NEUROLOGY (2004)

Add to Collection

Article Medicine, General & Internal

Topiramate for migraine prevention - A randomized controlled trial

JL Brandes et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)

Add to Collection

Article Clinical Neurology

Topiramate in migraine prophylaxis -: Results from a placebo-controlled trial with propranolol as an active control

HC Diener et al.

JOURNAL OF NEUROLOGY (2004)

Add to Collection

Article Clinical Neurology

Topiramate inhibits trigeminovascular neurons in the cat

RJ Storer et al.

CEPHALALGIA (2004)

Add to Collection

Article Clinical Neurology

Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study

D Mei et al.

NEUROLOGICAL SCIENCES (2004)

Add to Collection

Review Neurosciences

The neurobiology of antiepileptic drugs

MA Rogawski et al.

NATURE REVIEWS NEUROSCIENCE (2004)

Add to Collection

Article Clinical Neurology

Topiramate: a case series study in migraine prophylaxis

WB Young et al.

CEPHALALGIA (2002)

Add to Collection

Article Clinical Neurology

Efficacy of topiramate in migraine prophylaxis: A retrospective chart analysis

RL Von Seggern et al.

HEADACHE (2002)

Add to Collection

Article Clinical Neurology

Topiramate in migraine prevention: A double-blind, placebo-controlled study

JR Storey et al.

HEADACHE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.